Add to My Stocks
$6.69 $0.05 (0.74%) JNCE stock closing price Sep 19, 2018 (Closing)

The JOUNCE THERAPTC cash flow statement is one of the three reports that the company generates every quarter. While its important to look at the JOUNCE THERAPTC debt position, the cash flow statement becomes equally important because public companies use accrual accounting. For example, if a company sells a product which gets counted as JOUNCE THERAPTC revenue but does not convert to cash because it does not receive payment in the same quarter, it affects the cash position for that period. JOUNCE THERAPTC saw a cash impact of $107.47M from the issuance of JNCE shares. The cash flow statement helps in the JOUNCE THERAPTC stock analysis by providing more information for evaluating changes in assets, liabilities and equities. JOUNCE THERAPTC saw a outflow of $-38.02M from investing activities for 2017.

View details of JOUNCE THERAPTC cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec2017201620152014
Net Income Cash Flow
Depreciation Depletion Amortization Cash-Flow5.59M2.27M1.47M-
Net Increase (Decrease) in Assets Liabilities-84.73M186.13M1.83M-
Cash From (used in) Discontinued Operations----
Other Adjustments Net4.85M4.98M-0.5M-
Net Cash from (used by) Operating Activities
Increase (Decrease) in Prop Plant And Equipment-15.1M-2.22M-2.2M-
Acquisition Disposition of Subsidiaires----
Increase (Decrease) in Investments-22.91M-213.28M--
Other Cash Inflow (Outflow) from Investment Activities----
Net Cash from (used by) Investment Activities
Issuance (Purchase) of Equity Shares107.47M36.12M70.94M-
Issuance (Repayment) of Debt Securities----
Increase (Decrease) in Bank & Other Borrowings----
Payment of Dividends & Other Cash Distributions----
Other Cash from (used by) Financing Activities--0.62M-0.24M-
Net Cash from (used by) Financing Activities
Effect of Exchange Rate Changes on Cash----
Net Change in Cash & Cash Equivalents
Cash & Equivalents at Beginning of Year44.84M45.16M2.33M-
Cash & Equivalents at Year End23.55M44.84M45.16M-
All figures in USD. M: Millions of USD, B: Billions of USD.

JOUNCE THERAPTC stock comparison chart provides an easy way to compare the stock price with peers along with details of JOUNCE THERAPTC stock price history.
The statement of cash flows can be categorized into three main sections:

  • JOUNCE THERAPTC saw a negative change in Net Change in Cash and Cash Equivalents of $-21.28M in 2017. Apart from the JOUNCE THERAPTC stock price, this is one of the things an investor looks for, as it shows the net change in cash on hand for a company, compared to previous period.
  • Cash Flow from operating activities: Operating activities include the core business activities. This line item refers to the cash generated from the same and stood at a negative value of $-90.73M for JNCE.
  • Cash Flow from investment activities: JOUNCE THERAPTC used $-38.02M cash due to investment activities. It includes the use of cash outside of normal day to day activities like buying fixed assets, plant and machinery etc.
  • Cash flow from financing activities shows the flow of cash between JOUNCE THERAPTC and its owners and creditors and was $107.47M for 2017. Financing activities allow a company to raise capital, and repay bondholders.

Key Financial Ratios For JOUNCE THERAPTC Cash Flow

Annual Cash Flow Statements For JOUNCE THERAPTC Peers

Ardelyx cash flow, Galectin Therapeutics cash flow, Galmed Pharma cash flow